Table of Content

1 Hereditary Angioedema Drug Market Introduction and Overview
1.1 Hereditary Angioedema Drug Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Hereditary Angioedema Drug Revenue and Market Share by Manufacturer
2.2 Manufacturers Hereditary Angioedema Drug Production Sites, Area Served, Product Types
2.3 Hereditary Angioedema Drug Market Competitive Situation and Trends
2.3.1 Hereditary Angioedema Drug Market Concentration Rate
2.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2024
2.3.3 Mergers & Acquisitions, Expansion
3 Players Profiles
3.1 Pharming Group NV
3.1.1 Pharming Group NV Company Profile
3.1.2 Hereditary Angioedema Drug Product Overview
3.1.3 Pharming Group NV Hereditary Angioedema Drug Market Performance (2019-2024)
3.1.4 Pharming Group NV Business Overview
3.2 Shire plc
3.2.1 Shire plc Company Profile
3.2.2 Hereditary Angioedema Drug Product Overview
3.2.3 Shire plc Hereditary Angioedema Drug Market Performance (2019-2024)
3.2.4 Shire plc Business Overview
3.3 CSL Limited
3.3.1 CSL Limited Company Profile
3.3.2 Hereditary Angioedema Drug Product Overview
3.3.3 CSL Limited Hereditary Angioedema Drug Market Performance (2019-2024)
3.3.4 CSL Limited Business Overview
3.4 iBio Inc.
3.4.1 iBio Inc. Company Profile
3.4.2 Hereditary Angioedema Drug Product Overview
3.4.3 iBio Inc. Hereditary Angioedema Drug Market Performance (2019-2024)
3.4.4 iBio Inc. Business Overview
3.5 BioCryst Pharmaceuticals Inc.
3.5.1 BioCryst Pharmaceuticals Inc. Company Profile
3.5.2 Hereditary Angioedema Drug Product Overview
3.5.3 BioCryst Pharmaceuticals Inc. Hereditary Angioedema Drug Market Performance (2019-2024)
3.5.4 BioCryst Pharmaceuticals Inc. Business Overview
3.6 Ionis Pharmaceuticals Inc.
3.6.1 Ionis Pharmaceuticals Inc. Company Profile
3.6.2 Hereditary Angioedema Drug Product Overview
3.6.3 Ionis Pharmaceuticals Inc. Hereditary Angioedema Drug Market Performance (2019-2024)
3.6.4 Ionis Pharmaceuticals Inc. Business Overview
4 Global Hereditary Angioedema Drug Historical and Forecast Market Analysis by Type
4.1 Global Hereditary Angioedema Drug Revenue and Market Share by Type
4.2 Global Hereditary Angioedema Drug Revenue Market Forecast by Type (2024-2030)
5 Global Hereditary Angioedema Drug Historical and Forecast Market Analysis by Application
5.1 Global Hereditary Angioedema Drug Revenue Market Share by Application (2019-2024)
5.2 Hereditary Angioedema Drug Revenue Market Forecast by Application (2024-2030)
6 Global Market Growth Trends Analysis
6.1 Global Hereditary Angioedema Drug Market Size & Forecast (2019-2030)
6.2 Hereditary Angioedema Drug Growth Trends Analysis by Regions
6.2.1 Hereditary Angioedema Drug Market Size by Regions: 2019 VS 2024 VS 2030
6.2.2 Hereditary Angioedema Drug Historic Revenue Market Size by Regions (2019-2024)
6.2.3 Hereditary Angioedema Drug Forecasted Revenue Market Size by Regions (2024-2030)
6.2.4 North America Hereditary Angioedema Drug Market Size & Forecast (2019-2030)
6.2.5 Europe Hereditary Angioedema Drug Market Size & Forecast (2019-2030)
6.2.6 China Hereditary Angioedema Drug Market Size & Forecast (2019-2030)
6.2.7 Japan Hereditary Angioedema Drug Market Size & Forecast (2019-2030)
6.2.8 Korea Hereditary Angioedema Drug Market Size & Forecast (2019-2030)
6.2.9 Southeast Asia Hereditary Angioedema Drug Market Size & Forecast (2019-2030)
6.2.10 India Hereditary Angioedema Drug Market Size & Forecast (2019-2030)
6.2.11 South America Hereditary Angioedema Drug Market Size & Forecast (2019-2030)
6.2.12 Middle East & Africa Hereditary Angioedema Drug Market Size & Forecast (2019-2030)
7 North America
7.1 North America Hereditary Angioedema Drug Revenue by Players
7.2 North America Hereditary Angioedema Drug Revenue by Types
7.3 North America Hereditary Angioedema Drug Revenue by Applications
7.4 North America Hereditary Angioedema Drug Revenue, Gross and Gross Margin (2019-2024)
7.5 North America PEST Analysis
8 Europe
8.1 Europe Hereditary Angioedema Drug Revenue by Players
8.2 Europe Hereditary Angioedema Drug Revenue by Types
8.3 Europe Hereditary Angioedema Drug Revenue by Applications
8.4 Europe Hereditary Angioedema Drug Revenue, Gross and Gross Margin (2019-2024)
8.5 Europe PEST Analysis
9 China
9.1 China Hereditary Angioedema Drug Revenue by Players
9.2 China Hereditary Angioedema Drug Revenue by Types
9.3 China Hereditary Angioedema Drug Revenue by Applications
9.4 China Hereditary Angioedema Drug Revenue, Gross and Gross Margin (2019-2024)
9.5 China PEST Analysis
10 Japan
10.1 Japan Hereditary Angioedema Drug Revenue by Players
10.2 Japan Hereditary Angioedema Drug Revenue by Types
10.3 Japan Hereditary Angioedema Drug Revenue by Applications
10.4 Japan Hereditary Angioedema Drug Revenue, Gross and Gross Margin (2019-2024)
10.5 Japan PEST Analysis
11 Korea
11.1 Korea Hereditary Angioedema Drug Revenue by Players
11.2 Korea Hereditary Angioedema Drug Revenue by Types
11.3 Korea Hereditary Angioedema Drug Revenue by Applications
11.4 Korea Hereditary Angioedema Drug Revenue, Gross and Gross Margin (2019-2024)
11.5 Korea PEST Analysis
12 Southeast Asia
12.1 Southeast Asia Hereditary Angioedema Drug Revenue by Players
12.2 Southeast Asia Hereditary Angioedema Drug Revenue by Types
12.3 Southeast Asia Hereditary Angioedema Drug Revenue by Applications
12.4 Southeast Asia Hereditary Angioedema Drug Revenue, Gross and Gross Margin (2019-2024)
12.5 Southeast Asia PEST Analysis
13 India
13.1 India Hereditary Angioedema Drug Revenue by Players
13.2 India Hereditary Angioedema Drug Revenue by Types
13.3 India Hereditary Angioedema Drug Revenue by Applications
13.4 India Hereditary Angioedema Drug Revenue, Gross and Gross Margin (2019-2024)
13.5 India PEST Analysis
14 South America
14.1 South America Hereditary Angioedema Drug Revenue by Players
14.2 South America Hereditary Angioedema Drug Revenue by Types
14.3 South America Hereditary Angioedema Drug Revenue by Applications
14.4 South America Hereditary Angioedema Drug Revenue, Gross and Gross Margin (2019-2024)
14.5 South America PEST Analysis
15 Middle East & Africa
15.1 Middle East & Africa Hereditary Angioedema Drug Revenue by Players
15.2 Middle East & Africa Hereditary Angioedema Drug Revenue by Types
15.3 Middle East & Africa Hereditary Angioedema Drug Revenue by Applications
15.4 Middle East & Africa Hereditary Angioedema Drug Revenue, Gross and Gross Margin (2019-2024)
15.5 Middle East & Africa PEST Analysis
16 Hereditary Angioedema Drug Business Cost Analysis
16.1 Proportion of Business Cost Structure
16.1.1 Labor Cost
16.1.2 Operating Expenses
16.2 Hereditary Angioedema Drug Industrial Chain Analysis
17 Hereditary Angioedema Drug Industry Dynamic Analysis
17.1 Hereditary Angioedema Drug Market Trends Analysis
17.2 Hereditary Angioedema Drug Market Drivers Analysis
17.3 Hereditary Angioedema Drug Market Challenges Analysis
17.4 Hereditary Angioedema Drug Market Restraints Analysis
18 Research Findings and Conclusion